Articles
Original reporting and explainers on the science and business of living longer.
Breakthroughs
Insider Briefing: Longevity Clinical Trials Worth Watching Right Now
A working shortlist of active human trials in the senolytic, rapamycin-analog, and reprogramming spaces, and what would have to happen for each to actually matter.
Breakthroughs
Stem Cells, Cryonics, and the Drugs That Might Slow Aging: What People Are Actually Trying
From frozen bodies to repurposed diabetes drugs, here's what the people betting on medicine to beat aging are actually doing — and how far each bet really is from proven.
Breakthroughs
What's Already Been Done: A Century of Quiet Life Extension
Before gene therapy and senolytics, public health and medicine had already added decades to average life expectancy. It's worth remembering how.